Cumberland Pharmaceuticals Inc.
Hedge Funds Holdings
Last updated:
Cumberland Pharmaceuticals Inc.‘s stocks are currently a part of 10 hedge funds’ portfolios, which represents 10.46% of the total amount of its stocks outstanding. This makes up a total of 1.52M shares of Cumberland Pharmaceuticals Inc.. Compared to the previous quarter, the number fell by -38.91% or -970.09K shares fewer. As for the holding position changes, 20% (2) of current hedge fund investors increased the number of shares held, 50% (5) of current holders sold a part of the shares held, and 20% (2) closed the holdings completely.
Hedge funds holding Cumberland Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 29 |
|---|---|
| Q3 2018 | 31 |
| Q4 2018 | 25 |
| Q1 2019 | 23 |
| Q2 2019 | 22 |
| Q3 2019 | 27 |
| Q4 2019 | 25 |
| Q1 2020 | 23 |
| Q2 2020 | 26 |
| Q3 2020 | 24 |
| Q4 2020 | 25 |
| Q1 2021 | 29 |
| Q2 2021 | 26 |
| Q3 2021 | 20 |
| Q4 2021 | 23 |
| Q1 2022 | 24 |
| Q2 2022 | 20 |
| Q3 2022 | 15 |
| Q4 2022 | 22 |
| Q1 2023 | 10 |
Hedge funds changes in Cumberland Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 1 | 10 | 7 | 1 | 10 |
|---|---|---|---|---|---|
| Q3 2018 | 2 | 11 | 7 | 0 | 11 |
| Q4 2018 | 1 | 4 | 10 | 7 | 3 |
| Q1 2019 | 1 | 6 | 9 | 3 | 4 |
| Q2 2019 | 2 | 7 | 6 | 3 | 4 |
| Q3 2019 | 8 | 2 | 10 | 3 | 4 |
| Q4 2019 | 3 | 5 | 6 | 5 | 6 |
| Q1 2020 | 3 | 5 | 6 | 5 | 4 |
| Q2 2020 | 5 | 7 | 5 | 2 | 7 |
| Q3 2020 | 1 | 5 | 6 | 3 | 9 |
| Q4 2020 | 2 | 5 | 8 | 2 | 8 |
| Q1 2021 | 5 | 6 | 7 | 1 | 10 |
| Q2 2021 | 1 | 3 | 10 | 4 | 8 |
| Q3 2021 | 1 | 4 | 5 | 7 | 3 |
| Q4 2021 | 7 | 4 | 7 | 4 | 1 |
| Q1 2022 | 5 | 8 | 5 | 4 | 2 |
| Q2 2022 | 2 | 6 | 9 | 6 | -3 |
| Q3 2022 | 0 | 3 | 5 | 5 | 2 |
| Q4 2022 | 7 | 4 | 6 | 0 | 5 |
| Q1 2023 | 0 | 2 | 5 | 2 | 1 |
Hedge funds changes in Cumberland Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 1,000 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 144,000 | 0 |
| Q1 2022 | 133,000 | 0 |
| Q2 2022 | 128,000 | 0 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 4,500 | 0 |
| Q1 2023 | 3,143,000 | 0 |